Continental Investors Services Inc. Invests $12.60 Million in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Continental Investors Services Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 149,450 shares of the exchange traded fund’s stock, valued at approximately $12,600,000. SPDR S&P Biotech ETF makes up about 2.8% of Continental Investors Services Inc.’s portfolio, making the stock its 5th largest holding. Continental Investors Services Inc. owned approximately 0.17% of SPDR S&P Biotech ETF at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Barclays PLC grew its position in SPDR S&P Biotech ETF by 26.1% in the third quarter. Barclays PLC now owns 1,383,583 shares of the exchange traded fund’s stock valued at $109,745,000 after purchasing an additional 286,345 shares in the last quarter. Two Sigma Advisers LP bought a new position in SPDR S&P Biotech ETF in the third quarter valued at $105,480,000. Hsbc Holdings PLC grew its position in shares of SPDR S&P Biotech ETF by 23.0% in the 3rd quarter. Hsbc Holdings PLC now owns 974,615 shares of the exchange traded fund’s stock valued at $78,771,000 after acquiring an additional 182,486 shares during the period. Brown Advisory Inc. grew its position in shares of SPDR S&P Biotech ETF by 1,107.6% in the 3rd quarter. Brown Advisory Inc. now owns 970,255 shares of the exchange traded fund’s stock valued at $76,960,000 after acquiring an additional 889,912 shares during the period. Finally, JPMorgan Chase & Co. grew its position in shares of SPDR S&P Biotech ETF by 56.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 714,036 shares of the exchange traded fund’s stock valued at $53,032,000 after acquiring an additional 256,652 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $76.50 on Friday. The firm has a 50-day moving average of $84.76 and a 200-day moving average of $82.58. SPDR S&P Biotech ETF has a one year low of $61.78 and a one year high of $97.19. The company has a market cap of $7.19 billion, a PE ratio of 11.47 and a beta of 1.00.

About SPDR S&P Biotech ETF

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.